Judit H. Nyirady, M.D., M.B.A. joins LEO Pharma Inc. as Vice President of Medical Strategy & Scientific Affairs. Dr. Nyirady will be responsible for the medical and scientific affairs strategies for LEO Pharma in the United States, as well as the U.S. Quality, Pharmacovigilance, Drug Safety, and Medical Information functions.

"Dr. Nyirady joins LEO Pharma U.S. with extensive clinical development and scientific affairs credentials, and a proven record of accomplishments. She will play a critical role in achieving LEO Pharma's mission to help people suffering from skin diseases," stated Joergen Damsbo Andersen, interim President and CEO of LEO Pharma Inc.

Dr. Nyirady is a board certified dermatologist with over 18 years of pharmaceutical experience in all aspects of clinical research and development. She also has medical affairs expertise within both systemic and topical drugs.

Prior to joining LEO, Dr. Nyirady worked at Novartis, most recently as interim Medical Unit Head of Dermatology & Immunology, U.S. Clinical Development & Medical Affairs and concurrently as the Executive Director, Dermatology, U.S. Clinical Development & Medical Affairs. Before joining Novartis in 2003, Dr. Nyirady worked at Johnson & Johnson Consumer Products Worldwide (CPWW) as Director of Medical Affairs, Dermatology.

Dr. Nyirady holds a M.B.A. from Cornell University, Johnson Graduate School of Management and obtained her medical degree in Hungary from Albert Szent-Györgyi Medical University.

About LEO Pharma in the United States

LEO Pharma Inc. is a subsidiary of LEO Pharma A/S ("LEO Pharma"), serving the United States, helping people suffering from skin diseases with treatments for psoriasis, actinic keratosis and atopic dermatitis. It is based in Madison, NJ.

LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 4,800 people worldwide.

More information can be found at www.leo-pharma.us